Objective: To test a prediction model for sleep apnea based on clinical and sociodemographic variables in a population suspected of having sleep disorders and submitted to polysomnography. Methods: We included 323 consecutive patients submitted to polysomnography because of the clinical suspicion of having sleep disorders. We used a questionnaire with sociodemographic questions and the Epworth sleepiness scale. Blood pressure, weight, height, and SpO 2 were measured. Multiple linear regression was used in order to create a prediction model for sleep apnea, the apnea-hypopnea index (AHI) being the dependent variable. Multinomial logistic regression was used in order to identify factors independently associated with the severity of apnea (mild, moderate, or severe) in comparison with the absence of apnea. Results: The prevalence of sleep apnea in the study population was 71.2%. Sleep apnea was more prevalent in men than in women (81.2% vs. 56.8%; p < 0.001). The multiple linear regression model, using log AHI as the dependent variable, was composed of the following independent variables: neck circumference, witnessed apnea, age, BMI, and allergic rhinitis. The best-fit linear regression model explained 39% of the AHI variation. In the multinomial logistic regression, mild apnea was associated with BMI and neck circumference, whereas severe apnea was associated with age, BMI, neck circumference, and witnessed apnea. Conclusions: Although the use of clinical prediction models for sleep apnea does not replace polysomnography as a tool for its diagnosis, they can optimize the process of deciding when polysomnography is indicated and increase the chance of obtaining positive polysomnography findings.
severe sleep apnea goes untreated have been shown to be at a higher risk for cardiovascular events in a 10-year follow-up period than are controls with similar degrees of obesity. (10) Overnight polysomnography is indicated for the diagnosis of various sleep disorders, especially respiratory disorders. (1) Portable systems for home sleep monitoring are quickly becoming widely available on the market and are principally being used for the diagnosis of obstructive sleep apnea-hypopnea. The American Sleep Disorders Association recommends that this monitoring be restricted to patients with acute clinical symptoms or to settings in which classic polysomnography is not available. Its use is also acceptable in the treatment of patients who have already been diagnosed through conventional polysomnography. (11) The clinical impression alone has low accuracy for the diagnosis of sleep-disordered breathing, and polysomnography therefore remains indispensable. (12, 13) A meta-analysis of clinical studies for the diagnosis of obstructive sleep apnea revealed that clinical models have higher OR values for diagnosis and severity than do questionnaire-based models (10.49 and 17.24 vs. 5.02 and 10.12, respectively). (14) In that study, the clinical elements associated with an OR > 2 were BMI, arterial hypertension, and a history of nocturnal choking. The Epworth sleepiness scale showed an OR of 0.43 for diagnosis (95% CI: 0.13-1.48). Therefore, there is still a need for testing models that can improve the prediction of these disorders, optimizing the process of deciding when polysomnography is indicated. The overall objective of the present study was to test a clinical model designed to predict AHI based on clinical and sociodemographic variables in a population clinically suspected of having sleep disorders and referred for polysomnography.
Introduction
Sleep-disordered breathing is defined as a syndrome in which the frequency and severity of events are pathophysiologically associated with adverse health symptoms or outcomes.
The frequency of apnea and hypopnea is expressed by the apnea-hypopnea index (AHI), which corresponds to the sum of the number of apneas and hypopneas divided by the total hours of sleep. Severity is classified, based on the AHI, as mild (5-15 events/h), moderate (15-30 events/h), or severe (> 30 events/h). (1) A population-based study conducted in the city of São Paulo, Brazil, and using the second edition of the International Classification of Sleep Disorders, published by the American Academy of Sleep Medicine in 2005, showed the overall prevalence of obstructive sleep apnea to be 32.8% in the population studied. (2) When an AHI ≥ 5 events/h was used as the diagnostic criterion, the prevalence of sleep apnea in men tested in sleep laboratories was found to be 17-26%. (3) A prospective study on sleep conducted in the state of Wisconsin, USA, showed that, in terms of body weight, being 10% heavier at baseline was predictive of a 32% increase in the AHI (95% CI: 20-45%). (4) Conversely, being 10% lighter at baseline predicted a 26% decrease in the AHI (95% CI: 18-34%). Sleep apnea is also common in patients with craniofacial abnormalities. (5) Sleep fragmentation with arousals at the end of an apneic episode causes excessive sleepiness in some patients. Apnea-related variations in sympathetic discharge produce a specific pattern of oxyhemoglobin desaturation followed by normalization of saturation, potentially damaging the neurons that promote wakefulness. (6, 7) This injury contributes to learning disorders and is a possible explanation for the residual sleepiness found in sleep apnea patients despite appropriate treatment. (5) Heart rate and arterial pressure increase approximately five to seven seconds after the end of apnea, coinciding with arousal and oxyhemoglobin desaturation. (8, 9) There seems to be a relationship between apnea severity and the development of arterial hypertension, an association that persists even after adjustments have been made for confounding variables. (4) Patients in whom Resting heart rate was measured with the electrocardiogram sensor of the polysomnography system, there being a rest period of at least 5 min.
Oxyhemoglobin saturation was measured with a digital oximeter (Healthdyne Technologies, Marietta, GA, USA).
The parameters for defining the events and syndromes, for establishing the degrees of severity, and for standardizing the measurement methods, as well as the technical considerations that were used for interpreting the polysomnography findings, making the diagnosis, and issuing the final polysomnography report, were those established by the American Academy of Sleep Medicine. (1) The STATA statistical program, version 9.2 (Stata Corp., College Station, TX, USA), was used for statistical analysis.
Variables with normal distribution are expressed as means and standard deviations, whereas variables whose distribution is asymmetric or unknown are expressed as medians and interquartile ranges.
Pearson's chi-square test was used for determination of statistical significance for comparison of categorical variables. The Student's t-test was used for comparison of the means of the continuous variables with normal distribution, whereas the nonparametric MannWhitney test was used for comparison of the medians of the variables whose distribution was asymmetric or unknown.
Multiple linear regression was used in order to create a prediction model for sleep apnea, the AHI being the dependent variable. The variables that maintained a statistically significant association (p < 0.05) in the multivariate analysis remained in the final model. The linear regression model chosen was the one with the highest coefficient of determination (R 2 ) and whose variables showed, in addition to a statistically significant association, a strong clinical association with the AHI, based on data in the literature.
The F statistic was used for testing the statistical significance of the inclusion of each dependent variable in the model. The coefficient of determination R 2 was used for calculating the proportion of the total variation in AHI explained by each independent variable and by the set of independent variables. The adjusted daytime sleepiness, and periodic leg movements in sleep).
The exclusion criteria were being pregnant, being under 18 years of age, having a psychiatric disorder (history, treatment, or use of medications) or a mental disorder that prevented the completion of the questionnaires, being illiterate, and being or having been under treatment for sleep apnea.
The study was approved by the Research Ethics Committee of the Federal University of Minas Gerais (ruling no. 2006205212), and all participating patients gave written informed consent.
We used a general questionnaire, which was standardized by the clinical team and adapted to the study, containing questions related to sociodemographic, clinical, and lifestyle variables, together with the Epworth sleepiness scale (ESS). (15, 16) The ESS is designed to measure subjective daytime sleepiness. It was developed in 1991 (15) and has been validated for use in Brazil. (17) An ESS score of 10 was used as the cut-off point for distinguishing between normal and abnormal levels of daytime sleepiness. (16) Arterial pressure, expressed in mmHg, was measured with a Missouri device (Embu, Brazil) by the indirect method, with auscultation. Patients with an arterial pressure ≥ 140/90 mmHg or being treated with antihypertensive medication were defined as having systemic arterial hypertension. (18) Height, in centimeters, was measured with a stadiometer (Welmy S.A., Santa Bárbara do Oeste, Brazil). Weight, in kilograms, was measured with a scale (Welmy S.A.) The BMI was calculated as the weight in kilograms divided by the square of the height in meters weight (kg/m 2 ). Patients with a BMI of 25.0-29.9 kg/m 2 were classified as overweight, those with a BMI of 30.0-39.9 kg/m 2 were classified as obese, and those with a BMI > 40.0 kg/m 2 were classified as morbidly obese. Neck circumference, in centimeters, was measured at the level of the cricoarytenoid joint with a tape measure.
Overnight polysomnography with the recording of 16 channels for a minimum of 6 hours was conducted by a duly trained professional technician. All tests were performed with an Alice ® 3 polysomnography system (Respironics, Murrysville, PA, USA). was a predominance of married patients and of patients with a high level of education (90% had completed at least high school and 53.7% had completed college). Of the patients evaluated, 39.3% were overweight, 33.1% were obese, and 5.6% were morbidly obese. Table 1 shows the gender distribution of the study population by the characteristics under investigation. There were no gender-related differences in terms of age or marital status. Men and women differed significantly in terms of the distribution of BMI values, the percentage of obese patients being higher among men and the percentage of morbidly obese patients being higher among women. The median neck circumference was 40 cm, and there was a significant gender-related difference. The comorbidities most often reported were arterial hypertension, gastroesophageal reflux, allergic rhinitis, and depression. In comparison with the men, the women more often reported hypothyroidism (p < 0.001), depression (p < 0.001), and allergic rhinitis (p < 0.002).
The prevalence of sleep apnea in the study population was 71.2%, sleep apnea being classified as mild in 30.7% of the cases, as moderate in 10.0%, and as severe in 22.6%. Apnea was more common among men than among women (81.2% vs. 56.8%; p < 0.001), as were severe cases (30.4% vs. 11.4%). The median AHI was significantly higher for men than for women (14.3 events/h vs. 6.2 events/h; p < 0.0001; Table 2 ).
Although obstructive sleep apnea was the most common type of sleep apnea among men and women, the prevalence of all types of apnea was higher among men (p < 0.001).
There was no significant difference between the groups of patients with and without sleep apnea in terms of age. However, the prevalence of the disease increases in parallel with increasing age (60.5% among patients aged 18-29 years vs. 85.7% among patients aged 60 years or older). There were also no significant differences between the patients with and without apnea in terms of marital status or level of education. There was a statistically significant difference between the groups of patients with and without sleep apnea in terms of BMI, the prevalence of apnea increasing in parallel with increases in BMI (45.1%, 73.2%, 82.2%, and 94.4% for coefficient of determination R 2 was used for measuring the increase in variation explained in the multivariate model, after it had been decided that the variation in R 2 was simply random. The appropriateness of the linear regression model was tested graphically, and the assumption tests for the validity of the linear regression model available in the STATA software package were used. To fit these assumptions (normality of the distribution of residuals, homoscedasticity, and appropriateness of the model in terms of the inclusion of all relevant variables), the AHI was log-transformed, the variable "log AHI" being created.
The normality of the distribution of residuals was tested graphically and confirmed by a p value > 0.05 on the Shapiro-Wilk W test. (19) The assumption of homogeneity of variance of residuals (homoscedasticity) was also tested graphically and with the use of the decomposition of the information matrix test (STATA IM-test) as proposed by Cameron & Trivedi for regression models. (20) The strength of the correlations among the variables included in the model was tested by examining the variance inflation factor.
The appropriateness of the model in terms of the inclusion of all relevant variables was tested with the use of linktest and ovtest. The Ramsey regression specification error test was also used.
Finally, multinomial logistic regression analysis was used for identifying factors independently associated with the severity of apnea (mild, moderate, or severe) in comparison with the absence of apnea. Initially, univariate analysis was performed to determine the association of each independent variable with mild, moderate, and severe sleep apnea. After this analysis, all variables with a p value < 0.20 in the initial analysis were included in the multivariate analysis, whereas only those with a p value < 0.05 remained in the final model. The magnitude of the association was expressed in ORs and 95% CIs.
Results
Of the 323 patients, 191 (59.13%) were male and 132 (40.87%) were female. Patient ages ranged from 18 to 79 years, the median age was 34.7 years, and the mean age was 44.6 ± 12.0 years. Approximately 75% of the patients were between 30 and 60 years of age. There The multiple linear regression model that best fit the assumptions and obtained the highest R 2 , using log AHI as the dependent variable, was composed of the following independent variables: neck circumference (cm); witnessed apnea (yes = 1); age (years); BMI (kg/m 2 ); and allergic rhinitis (yes = 1). This model explained approximately 39% of the variation in the log individuals classified as normal BMI, overweight, obese, and morbidly obese, respectively).
The mean neck circumference in the groups of patients with and without sleep apnea was 38 cm and 42 cm, respectively (p < 0.001). Arterial hypertension (p = 0.010) and diabetes (p = 0.001) were the most common comorbidities in the group of patients with sleep apnea (Table 3) . 
Discussion
In the present study, sleep apnea was diagnosed in more than two thirds of the study population, suggesting that clinical screening identified and eliminated most of the falsepositive results. The prevalence of sleep apnea found in the present study was much higher than that reported in studies based on the general population, although it is similar to that reported in clinical studies of populations suspected of having this disease. (21, 22) The frequency of sleep apnea was significantly higher in male patients, the male/ female ratio being The multinomial logistic regression analysis (Tables 4 and 5 ), used for investigating the association of several independent variables with the severity of sleep apnea (mild, moderate, or severe), revealed that mild apnea was significantly associated with BMI and neck circumference, whereas severe apnea was associated with age, BMI, neck circumference, and witnessed apnea. Evaluation of a prediction model for sleep apnea in patients submitted to polysomnography J Bras Pneumol. 2011;37(1):75-84 81 statistically significant factor in the final linear regression model, possibly due to the fact that gender was strongly associated with the variables that remained in the final model, especially BMI, neck circumference, and witnessed apnea. The prevalence of obesity-overall obesity, as measured by BMI, and localized obesity, as estimated by neck circumference-was high in the study population. These two variables were also significant in predicting log AHI and were independently associated with sleep apnea of any level of severity, as shown in the multinomial regression model. In middle-aged adults, obesity is the major risk factor for sleep apnea. (5, 26) We found that sleep apnea was associated with hypertension and diabetes but not with other comorbidities or lifestyle. A populationbased case-control study in which patients with sleep apnea were matched to controls for age, gender, zip code, and physician they had seen in the last 2 years revealed that treatment for cardiovascular diseases in general was more common among the patients with sleep apnea, as was treatment for arterial hypertension, congestive heart failure, cardiac arrhythmia, and chronic obstructive airway disease. (27) These population-based studies have shown prevalence ratios ranging from 2:1 to 3:1. (23) One of the hypotheses to explain this higher frequency in men is that the clinical presentation of sleep apnea is less typical in women and this would lead to underdiagnosis, which means that a gender bias is likely. The clinical presentation of sleep apnea is more typical in men, there being a higher frequency of snoring and witnessed apnea. The female population has less specific symptoms, such as depression, excessive sleepiness, and fatigue, which are often believed to have causes other than sleep apnea; this explains why these patients are less frequently referred for polysomnography. Studies of sleep apnea symptoms in clinical populations have shown that 40% of women with the disease report no witnessed apnea, nocturnal choking, or nonrestorative sleep, whereas most men do. (24) Another group of authors, studying genderrelated differences in sleep apnea and using the AHI cut-off point of 5 events/h for diagnosis, reported a prevalence of 9% for women and a prevalence of 24% for men. (25) In the present study, sleep apnea was more common in men. However, gender was not a findings are similar to ours in terms of arterial hypertension. Our finding that, in the final model, sleep apnea did not correlate with the remaining comorbidities can be explained by a lack of statistical power, due to the small number of cases. Our linear regression model for predicting log AHI explained 39% of the variation in the variable "response". The use of upper-airway anatomical findings, identified by physical examination, as has been done in some previous studies but not in the present study, might have increased the efficiency of these models.
After adjusting for the various confounding variables in the multinomial logistic regression, we found that age, BMI, neck circumference, and witnessed apnea remained statistically associated with mild, moderate, or severe sleep apnea, BMI being the variable with the greatest strength of association for all degrees of severity. There have been several attempts to predict sleep apnea without the use of polysomnography. Those models differ in terms of the variables included and the case definitions, making it difficult to compare the results across studies. (12, 13, 27, 28) The use of multiple regression analyses with the inclusion of clinical variables has produced good prediction models. In a prospective study evaluating four AHI prediction models, their sensitivity was found to be high (85-98%), although their specificity was low (33-39%). (29) The variables included in those models were witnessed apnea, arterial hypertension, BMI, age, snoring, neck circumference, and gender. (30) Our study was based on a selected population of patients, which limits the external validity of our results in terms of estimating the prevalence of sleep apnea. Although it is not possible to extrapolate our findings to the general population or to a population qualitatively different from that of the present study, the use of prediction models is an important tool for screening patients suspected of having sleep disorders and optimizing the process of deciding when polysomnography is indicated. The use of clinical and sociodemographic variables added little value to the identification of patients with sleep apnea among patients clinically suspected of having sleep disorders and referred for polysomnography. It is possible that the information included in the present study more appropriately explains the AHI variation in the
